4:59 PM ET
8-K
Shareholder Meeting
Rallybio Shareholder Meeting
Rallybio Corporation held its 2026 Annual Meeting of Stockholders where shareholders approved the 2026 Equity Incentive Plan. The plan, which becomes effective upon the completion of the company's merger with Avenzo Therapeutics, initially reserves 18% of the combined company's outstanding common stock for issuance to employees and directors.